Combinations of kynurenine and antigen presenting cells (APC) as therapeutic agents in immune modulation and methods for their use in immune modulation

摘要

The present invention provides a combination of kynurenine and antigen presenting cells (APC) to modulate immune involvement, said combination being a modulation of the autoimmune response, type 1 diabetes (T1D) and alopecia areata (AA) It may be used in therapy for the treatment of Also provided is the use of kynurenine and antigen presenting cells (APC) as immunomodulators for the treatment of T1D or AA.